Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 542 Records) |
| Query Trace: Neoplasms and ERBB2[original query] |
|---|
| Frequency of genetic alterations differs in advanced breast cancer between metastatic sites. Genes, chromosomes & cancer 2023 9 . Isabel Grote, Alexandra Poppe, Ulrich Lehmann, Matthias Christgen, Hans Kreipe, Stephan Barte |
| Pooled ctDNA analysis of MONALEESA phase III advanced breast cancer trials. Annals of oncology : official journal of the European Society for Medical Oncology 2023 9 . F André, F Su, N Solovieff, G Hortobagyi, S Chia, P Neven, A Bardia, D Tripathy, Y-S Lu, A Lteif, T Taran, N Babbar, D Slamon, C L Artea |
| Overall signature of acquired KRAS gene changes in advanced non-small cell lung cancer patient with EGFR-TKI resistance. Japanese journal of clinical oncology 2023 9 . Jie Zheng, Yuanyao Dou, Daijuan Huang, Yubo Wang, Rui Han, Chen Hu, Mengxiao Zhu, Conghua Lu, Caiyu Lin, Di Wu, Yihui Liu, Huan Tang, Tingting He, Weilin Jiang, Yong |
| Compromised Outcomes in Stage IV Non-Small-Cell Lung Cancer With Actionable Mutations Initially Treated Without Tyrosine Kinase Inhibitors: A Retrospective Analysis of Real-World Data. JCO oncology practice 2023 8 OP2200611. Jeffrey A Scott, Jochen Lennerz, Melissa Lynne Johnson, Lucio N Gordan, Robert H Dumanois, Luca Quagliata, Lauren L Ritterhouse, Federico Cappuzzo, Brandon Wang, Mei Xue, Anupama Vasudevan, Prateesh Varughese, Varun Vaidya, Mike Gart, Natalie Dorrow, Hinco J Gierman, Rushir J Chok |
| Concurrent predictors of an immune responsive tumor microenvironment within tumor mutational burden-high breast cancer. Frontiers in oncology 2023 8 13 1235902. Sarah Sammons, Andrew Elliott, Romualdo Barroso-Sousa, Saranya Chumsri, Antoinette R Tan, George W Sledge, Sara M Tolaney, Evanthia T Roussos Torr |
| Monitoring the Outcomes of Systemic Chemotherapy Including Immune Checkpoint Inhibitor for HER2-Positive Metastatic Gastric Cancer by Liquid Biopsy. Yonsei medical journal 2023 8 64 (9): 531-540. Seung-Hyun Jung, Choong-Kun Lee, Woo Sun Kwon, Sujin Yun, Minkyu Jung, Hyo Song Kim, Hyun Cheol Chung, Yeun-Jun Chung, Sun Young R |
| EGFR co-mutation is associated with the risk of recurrence in invasive lung adenocarcinoma with the micropapillary component. Asian journal of surgery 2023 8 . Haixin Kang, Haiyan Lv, Tao-Hsin Tung, Dehua Ma, Zheng Wang, Juping Du, Kai Zhou, Juan Pan, Yanjie Zhang, Shuotao Peng, Zhaonan Yu, Bo Shen, Minhua |
| Unique Genomic Alterations and Microbial Profiles Identified in Gastric Cancer Patients of African, European, and Asian Ancestry: A Novel Path for Precision Oncology. Annals of surgery 2023 7 . Miseker Abate, Henry Walch, Kanika Arora, Chad M Vanderbilt, Teng Fei, Harrison Drebin, Shoji Shimada, Anna Maio, Yelena Kemel, Zsofia K Stadler, Joseph Schmeltz, Smita Sihag, Geoffrey Y Ku, Ping Gu, Laura Tang, Santosha Vardhana, Michael F Berger, Murray F Brennan, Nikolaus D Schultz, Vivian E Stro |
| Supratentorial Sporadic Hemangioblastoma: A Case Report With Mutation Profiling Using Next-Generation DNA Sequencing. Cureus 2023 6 15 (6): e39818. Mohiuddin M Taher, Najwa A Bantan, Mustafa H Alwalily, Muhammad Saeed, Nuha M Taher, Meriem Bouzidi, Raid A Jastania, Kamal B Balkhoyo |
| Genomics of ERBB2-Positive Breast Cancer in Young Women Before and After Exposure to Chemotherapy Plus Trastuzumab. JCO precision oncology 2023 6 7 e2300076. Marla Lipsyc-Sharf, Esha Jain, Laura C Collins, Shoshana M Rosenberg, Kathryn J Ruddy, Rulla M Tamimi, Lidia Schapira, Steven E Come, Jeffrey M Peppercorn, Virginia F Borges, Ellen Warner, Craig Snow, Ian E Krop, Dewey Kim, Jakob Weiss, Jorge Gomez Tejeda Zanudo, Ann H Partridge, Nikhil Wagle, Adrienne G Wa |
| Exploration of HER2 (ERBB2) immunohistochemistry in non-small cell lung cancer: correlation with ERBB2 mutational status: experimental research. Annals of medicine and surgery (2012) 2023 6 85 (6): 2640-2646. Anthony B Cardillo, Sierra Kovar, Nitin Roper, David G Hicks, Moises J Vel |
| CDK12 alterations and ARID1A mutations are predictors of poor prognosis and therapeutic targets in high-grade salivary gland carcinoma: analysis of the National Genomic Profiling Database. Japanese journal of clinical oncology 2023 6 . Kenya Kobayashi, Yuki Saito, Hidenori Kage, Osamu Fukuoka, Koji Yamamura, Toshiyuki Mukai, Katsutoshi Oda, Tatsuya Yamaso |
| The differences in immune features and genomic profiling between squamous cell carcinoma and adenocarcinoma - A multi-center study in Chinese patients with uterine cervical cancer. Gynecologic oncology 2023 6 175 133-141. Jin Li, Xiaohong Xue, Yan Zhang, Fengna Ding, Wenyan Wu, Cuicui Liu, Yang Xu, Hanlin Chen, Qiuxiang Ou, Yang Shao, Xinjun Li, Fei Wu, Xiaohua |
| Pertuzumab Plus Trastuzumab in Patients With Lung Cancer With ERBB2 Mutation or Amplification: Results From the Targeted Agent and Profiling Utilization Registry Study. JCO precision oncology 2023 6 7 e2300041. Apar K Ganti, Michael Rothe, Pam K Mangat, Elizabeth Garrett-Mayer, Elie G Dib, Herbert L Duvivier, Eugene R Ahn, Deepti Behl, Hossein Borghaei, Ani S Balmanoukian, Anu Gaba, Rui Li, Kwabena Osei-Boateng, Ramya Thota, Gina N Grantham, Abigail Gregory, Susan Halabi, Richard L Schils |
| Significance of the FGFR3 mutation in Chinese patients with bladder cancer. Translational andrology and urology 2023 6 12 (5): 761-769. Lanxiang Hao, Jiang Fang, Ran Xu, Shuo Liu, Guangcheng Luo, Xinjun Wa |
| Profiling the somatic mutational landscape of breast tumors from Hispanic/Latina women reveals conserved and unique characteristics. Cancer research 2023 5 . Yuan Chun Ding, Hanbing Song, Aaron W Adamson, Daniel Schmolze, Donglei Hu, Scott Huntsman, Linda Steele, Carmina S Patrick, Shu Tao, Natalie Hernandez, Charleen D Adams, Laura Fejerman, Kevin Gardner, Anna María Nápoles, Eliseo J Perez-Stable, Jeffrey N Weitzel, Henrik Bengtsson, Franklin W Huang, Susan L Neuhausen, Elad Z |
| ARID1A Mutation from Targeted NGS Predicts Primary Resistance to Gemcitabine and Cisplatin Chemotherapy in Advanced Biliary Tract Cancer. Cancer research and treatment 2023 5 . Sung Hwan Lee, Jaekyung Cheon, Seoyoung Lee, Beodeul Kang, Chan Kim, Hyo Sup Shim, Young Nyun Park, Sanghoon Jung, Sung Hoon Choi, Hye Jin Choi, Choong-Kun Lee, Hong Jae Ch |
| Genomic characteristics and prognosis of lung cancer patients with MSI-H: A cohort study. Lung cancer (Amsterdam, Netherlands) 2023 5 181 107255. Jie Tian, Hongdan Wang, Conghua Lu, Lan Liu, Xianquan Zhang, Yunbo Xie, Rutian Li, Xin Lv, Dan Fu, Ling Zhang, Xisheng Fang, Xuming Wang, Jing Hu, Xinyi Liu, Xiaochun Huang, Qian Zhao, Nuo Luo, Huan Tang, Zhaoyang Zhong, Yong He, Li |
| Panitumumab Plus Trifluridine-Tipiracil as Anti-Epidermal Growth Factor Receptor Rechallenge Therapy for Refractory RAS Wild-Type Metastatic Colorectal Cancer: A Phase 2 Randomized Clinical Trial. JAMA oncology 2023 5 . Stefania Napolitano, Vincenzo De Falco, Giulia Martini, Davide Ciardiello, Erika Martinelli, Carminia Maria Della Corte, Lucia Esposito, Vincenzo Famiglietti, Alessandra Di Liello, Antonio Avallone, Claudia Cardone, Alfonso De Stefano, Vincenzo Montesarchio, Maria Giulia Zampino, Roberto Bordonaro, Mario Scartozzi, Daniele Santini, Massimo Di Maio, Ferdinando De Vita, Lucia Altucci, Francesca Marrone, Fortunato Ciardiello, Teresa Troia |
| The Unique Genetic Mutation Characteristics Based on Large Panel Next-Generation Sequencing (NGS) Detection in Multiple Primary Lung Cancers (MPLC) Patients. Discovery medicine 2023 5 35 (175): 131-143. Zhu Liang, Guoxiong Zeng, Wang Wan, Biao Deng, Chunyuan Chen, Fasheng Li, Guanzhou Lin, Yuying Lin, Haitao Lin, Guixi Mo, Huilai Mi |
| Pertuzumab Plus Trastuzumab in Patients With Endometrial Cancer With ERBB2/3 Amplification, Overexpression, or Mutation: Results From the TAPUR Study. JCO precision oncology 2023 4 7 e2200609. Ahn Eugene R, Rothe Michael, Mangat Pam K, Garrett-Mayer Elizabeth, Ali-Ahmad Hussein M, Chan John, Maitland Michael L, Patel Sapna R, Reese Zachary, Balmanoukian Ani S, Drescher Charles W, Li Rui, Tsimberidou Apostolia M, Leath Charles A, O'Lone Raegan, Grantham Gina N, Halabi Susan, Schilsky Richard |
| Association between vascular ultrasound features and DNA sequencing in breast cancer: a preliminary study. Discover. Oncology 2023 4 14 (1): 52. Mi-Ryung Han, Ah Young Park, Bo Kyoung Seo, Min Sun Bae, Jung Sun Kim, Gil Soo Son, Hye Yoon Lee, Young Woo Chang, Kyu Ran Cho, Sung Eun Song, Ok Hee Woo, Hye-Yeon Ju, Hyunseung |
| Somatic mutation detection and KRAS amplification in testicular germ cell tumors. Frontiers in oncology 2023 4 13 1133363. Cabral Eduardo R M, Pacanhella Marilia F, Lengert Andre V H, Dos Reis Mariana B, Leal Leticia F, de Lima Marcos A, da Silva Aline L V, Pinto Icaro A, Reis Rui M, Pinto Mariana T, Cárcano Flavio |
| Genomically matched therapy in refractory colorectal cancer according to ESMO Scale for Clinical Actionability of Molecular Targets: experience of a comprehensive cancer center network. Molecular oncology 2023 4 . Núria Mulet Margalef, Carmen Castillo, Miguel Mosteiro, Xavier Pérez, Susana Aguilar, Fiorella Ruíz-Pace, Marta Gil, Carmen Cuadra, José Carlos Ruffinelli, Mercedes Martínez, Ferran Losa, Gema Soler, Àlex Teulé, Roser Castany, Rosa Gallego, Andrea Ruíz, Elena Garralda, Elena Élez, Ana Vivancos, Josep Tabernero, Ramon Salazar, Rodrigo Dienstmann, Cristina Sant |
| Genomic landscape and survival analysis of ctDNA "neo-RAS wild-type" patients with originally RAS mutant metastatic colorectal cancer. Frontiers in oncology 2023 4 13 1160673. Nicolazzo Chiara, Magri Valentina, Marino Luca, Belardinilli Francesca, Di Nicolantonio Federica, De Renzi Gianluigi, Caponnetto Salvatore, De Meo Michela, Giannini Giuseppe, Santini Daniele, Cortesi Enrico, Gazzaniga Pao |
| Pathogenic genomic alterations in Chinese pancreatic cancer patients and their therapeutical implications. Cancer medicine 2023 3 . Zhao Zhiming, Li Xiaomo, Wang Fei, Xu Yong, Liu Si, Han Quanli, Yang Zhiying, Huang Weiwei, Yin Zhuzeng, Liu Qu, Tan Haidong, Ma Tonghui, Si Shuang, Huang Jia, Yuan Hongling, Li Wei, Liu Ro |
| Racial Disparities in Pathological Complete Response Among Patients Receiving Neoadjuvant Chemotherapy for Early-Stage Breast Cancer. JAMA network open 2023 3 6 (3): e233329. Zhao Fangyuan, Miyashita Minoru, Hattori Masaya, Yoshimatsu Toshio, Howard Frederick, Kaneva Kristiyana, Jones Ryan, Bell Joshua S K, Fleming Gini F, Jaskowiak Nora, Nanda Rita, Zheng Yonglan, Huo Dezheng, Olopade Olufunmilayo |
| Molecular Landscape of Mullerian Clear Cell Carcinomas Identifies The Cancer Genome Atlas-like Prognostic Subgroups. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2023 3 36 (5): 100123. Irshaid Lina, Costigan Danielle C, Dong Fei, Matulonis Ursula A, Nucci Marisa R, Kolin David |
| Novel mutant KRAS addiction signature predicts response to the combination of ERBB and MEK inhibitors in lung and pancreatic cancers. iScience 2023 2 26 (3): 106082. Tyc Katarzyna M, Kazi Aslamuzzaman, Ranjan Alok, Wang Rui, Sebti Said |
| Comprehensive biomarker analysis of long-term response to trastuzumab in patients with HER2-positive advanced gastric or gastroesophageal adenocarcinoma. European journal of cancer (Oxford, England : 1990) 2023 2 183 119-130. Porth Isabel, Hirsch Daniela, Ceribas Yonca, Weidner Philip, Weichert Wilko, Götze Thorsten Oliver, Perner Sven, Luley Kim, Heyer Christian Moritz, de la Torre Carolina, Hofheinz Ralf-Dieter, Lorenzen Sylvie, Gaiser Ti |
- Page last reviewed:Feb 1, 2023
- Page last updated:Sep 29, 2023
- Content source: